+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Nucleic Acid Testing - Global Strategic Business Report

  • PDF Icon

    Report

  • 372 Pages
  • February 2025
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 1244792
The global market for Nucleic Acid Testing was valued at US$3.4 Billion in 2024 and is projected to reach US$4.4 Billion by 2030, growing at a CAGR of 4.5% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Nucleic Acid Testing Market - Key Trends and Drivers Summarized

Nucleic Acid Testing (NAT) is a sophisticated biological technique used to detect specific sequences of DNA or RNA in a sample. This method has become indispensable in various fields, including medical diagnostics, forensic science, and biological research. Nucleic Acid Testing (NAT) is a vital molecular technique employed in various diagnostic and screening applications, particularly in the medical field. It utilizes advanced methodologies to detect the specific sequences of DNA or RNA from viruses, bacteria, or other pathogens present in blood, urine, or tissues. One of the primary drivers of the NAT market is its increasing use in medical diagnostics. NAT offers a highly sensitive method for detecting pathogens, including viruses and bacteria that cause diseases. Its ability to detect genetic material directly from pathogens enables earlier and more accurate diagnosis compared to traditional methods like culture techniques. This is particularly critical in the diagnosis of infectious diseases such as HIV, hepatitis B and C, tuberculosis, and COVID-19, where timely and precise detection can significantly influence treatment outcomes and patient recovery.

Technological advancements are propelling the NAT market forward by enhancing the capabilities and accessibility of this testing method. Improvements in polymerase chain reaction (PCR), real-time PCR, and next-generation sequencing (NGS) have broadened NAT's applications, making it faster, more accurate, and cost-effective. Additionally, the development of portable and point-of-care NAT devices allows for immediate diagnoses, extending the technology's reach beyond traditional lab settings into immediate patient care scenarios. These innovations support the growing trend toward personalized medicine, where treatments are tailored based on individual genetic profiles, improving treatment efficacy and patient safety. NAT is crucial in genotyping, pharmacogenomics, and cancer genomics, helping to identify genetic mutations that may influence the effectiveness of certain therapies. This precise approach enhances treatment efficacy and minimizes adverse drug reactions, leading to better patient outcomes.

The increasing application of NAT in genetic testing, forensic science, and the support of regulatory bodies and governments further boost market growth. NAT's ability to detect and quantify minute amounts of genetic material makes it invaluable in genetic research and diagnostics, as well as in forensic applications for identifying individuals in criminal investigations and disaster victim identification. As technology continues to evolve, the demand for precise and rapid diagnostics is expected to drive substantial growth in the NAT market, affirming its integral role in healthcare and scientific advancements.

Report Scope

The report analyzes the Nucleic Acid Testing market, presented in terms of market value (USD). The analysis covers the key segments and geographic regions outlined below.

Segments

Product Type (Nucleic Acid Test Kits, Consumables); End-Use (Research Institutes, Pathology Laboratories, Hospitals, Clinics).

Geographic Regions/Countries

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Nucleic Acid Test Kits segment, which is expected to reach US$3.7 Billion by 2030 with a CAGR of a 5%. The Nucleic Acid Testing Consumables segment is also set to grow at 1.7% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $905 Million in 2024, and China, forecasted to grow at an impressive 7.7% CAGR to reach $950.8 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Nucleic Acid Testing Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Nucleic Acid Testing Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Nucleic Acid Testing Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Abbott Molecular, Inc., Beckman Coulter - Life Science Division, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 46 companies featured in this Nucleic Acid Testing market report include:

  • Abbott Molecular, Inc.
  • Beckman Coulter - Life Science Division
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • Novartis International AG
  • Sequenom, Inc.
  • Siemens Healthineers
  • Tecan Group Ltd.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Nucleic Acid Testing - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • Global Economic Update
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Infectious Diseases Drives Nucleic Acid Testing Market Growth
  • Technological Advancements in PCR and NGS Propel Market Expansion
  • Increasing Adoption in Clinical Diagnostics Expands Addressable Market
  • Rising Demand for Point-of-Care Testing Generates Market Opportunities
  • Expansion of Molecular Diagnostic Laboratories Accelerates Market Growth
  • Growing Focus on Early Disease Detection Sustains Market Growth
  • Increasing Use in Oncology and Cancer Research Spurs Market Adoption
  • Advances in CRISPR and Gene Editing Technologies Generate Market Opportunities
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Nucleic Acid Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 2: World Historic Review for Nucleic Acid Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 3: World 15-Year Perspective for Nucleic Acid Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Nucleic Acid Test Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 5: World Historic Review for Nucleic Acid Test Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 6: World 15-Year Perspective for Nucleic Acid Test Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 8: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 9: World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 11: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 12: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Pathology Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 14: World Historic Review for Pathology Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 15: World 15-Year Perspective for Pathology Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 17: World Historic Review for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 18: World 15-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 19: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 20: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 21: World 15-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 22: World Nucleic Acid Testing Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Nucleic Acid Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • Table 23: USA Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 24: USA Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 25: USA 15-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2015, 2025 & 2030
  • Table 26: USA Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 27: USA Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 28: USA 15-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2015, 2025 & 2030
CANADA
  • Table 29: Canada Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 30: Canada Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 31: Canada 15-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2015, 2025 & 2030
  • Table 32: Canada Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 33: Canada Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 34: Canada 15-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2015, 2025 & 2030
JAPAN
  • Nucleic Acid Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • Table 35: Japan Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 36: Japan Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 37: Japan 15-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2015, 2025 & 2030
  • Table 38: Japan Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 39: Japan Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 40: Japan 15-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2015, 2025 & 2030
CHINA
  • Nucleic Acid Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • Table 41: China Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 42: China Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 43: China 15-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2015, 2025 & 2030
  • Table 44: China Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 45: China Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 46: China 15-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2015, 2025 & 2030
EUROPE
  • Nucleic Acid Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • Table 47: Europe Recent Past, Current & Future Analysis for Nucleic Acid Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 48: Europe Historic Review for Nucleic Acid Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 49: Europe 15-Year Perspective for Nucleic Acid Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • Table 50: Europe Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 51: Europe Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 52: Europe 15-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2015, 2025 & 2030
  • Table 53: Europe Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 54: Europe Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 55: Europe 15-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2015, 2025 & 2030
FRANCE
  • Nucleic Acid Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • Table 56: France Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 57: France Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 58: France 15-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2015, 2025 & 2030
  • Table 59: France Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 60: France Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 61: France 15-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2015, 2025 & 2030
GERMANY
  • Nucleic Acid Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • Table 62: Germany Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 63: Germany Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 64: Germany 15-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2015, 2025 & 2030
  • Table 65: Germany Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 66: Germany Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 67: Germany 15-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2015, 2025 & 2030
ITALY
  • Table 68: Italy Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 69: Italy Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 70: Italy 15-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2015, 2025 & 2030
  • Table 71: Italy Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 72: Italy Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 73: Italy 15-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2015, 2025 & 2030
UNITED KINGDOM
  • Nucleic Acid Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • Table 74: UK Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 75: UK Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 76: UK 15-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2015, 2025 & 2030
  • Table 77: UK Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 78: UK Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 79: UK 15-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2015, 2025 & 2030
SPAIN
  • Table 80: Spain Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 81: Spain Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 82: Spain 15-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2015, 2025 & 2030
  • Table 83: Spain Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 84: Spain Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 85: Spain 15-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2015, 2025 & 2030
RUSSIA
  • Table 86: Russia Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 87: Russia Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 88: Russia 15-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2015, 2025 & 2030
  • Table 89: Russia Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 90: Russia Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 91: Russia 15-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2015, 2025 & 2030
REST OF EUROPE
  • Table 92: Rest of Europe Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 93: Rest of Europe Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 94: Rest of Europe 15-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2015, 2025 & 2030
  • Table 95: Rest of Europe Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 96: Rest of Europe Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 97: Rest of Europe 15-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2015, 2025 & 2030
ASIA-PACIFIC
  • Nucleic Acid Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • Table 98: Asia-Pacific Recent Past, Current & Future Analysis for Nucleic Acid Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 99: Asia-Pacific Historic Review for Nucleic Acid Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 100: Asia-Pacific 15-Year Perspective for Nucleic Acid Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • Table 101: Asia-Pacific Recent Past, Current & Future Analysis for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 102: Asia-Pacific Historic Review for Nucleic Acid Testing by Product Type - Nucleic Acid Test Kits and Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 103: Asia-Pacific 15-Year Perspective for Nucleic Acid Testing by Product Type - Percentage Breakdown of Value Sales for Nucleic Acid Test Kits and Consumables for the Years 2015, 2025 & 2030
  • Table 104: Asia-Pacific Recent Past, Current & Future Analysis for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • Table 105: Asia-Pacific Historic Review for Nucleic Acid Testing by End-Use - Research Institutes, Pathology Laboratories, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 106: Asia-Pacific 15-Year Perspective for Nucleic Acid Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pathology Laboratories, Hospitals and Clinics for the Years 2015, 2025 & 2030
AUSTRALIA
  • Nucleic Acid Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
INDIA
  • Nucleic Acid Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Nucleic Acid Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Nucleic Acid Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Nucleic Acid Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Molecular, Inc.
  • Beckman Coulter - Life Science Division
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • Novartis International AG
  • Sequenom, Inc.
  • Siemens Healthineers
  • Tecan Group Ltd.

Table Information